PRIMARY HEALTH PROPERTIES PLC - Results for the year ended 31 December 2025
What this filing means
Primary Health Properties reports mixed post-merger results, with strong top-line scale and synergy delivery offset by declining HEPS, NAV dilution, and increased balance sheet leverage.
The company grew much larger after a major merger, which boosted its total rental income and allowed it to keep raising its dividend. However, the costs and structure of the merger caused its debt levels to rise and its core profit per share to fall slightly.
Bull case
- Net rental income surged by 49% to £230 million, reflecting the immediate scale benefits of the Assura merger.
- The company maintained its 30-year track record of consecutive dividend growth, with the 7.1p dividend fully covered by adjusted earnings.
- Post-merger integration is progressing ahead of schedule, with over 80% of targeted annualised transaction synergies already delivered.
- Rental growth momentum remains strong, with 2025 growth of 3.2% beating guidance and early 2026 reviews annualising at 3.4%.
Bear case
- Balance sheet leverage has deteriorated significantly, with the loan-to-value ratio rising to 57%, well above the target range of 40% to 50%.
- Per-share value has been diluted, evidenced by a 4.62% drop in HEPS and a 4.85% decline in IFRS net tangible assets per share.
- The debt profile has worsened, showing a compressed weighted average maturity of 4.1 years and an increased average cost of debt of 3.7%.
- Income quality saw a slight contraction, with government-funded rent-roll dropping from 89% to 76%.
AI-generated summary by SENS-AI, based on the original JSE SENS filing.
SENS-AI conclusion
Primary Health Properties reported its full-year results for 2025 following the Assura combination, showing a 49% increase in net rental income alongside a 4.62% decline in headline earnings per share and a drop in net tangible assets to 98 pence. While the transformational merger successfully delivered over 80% of targeted synergies ahead of schedule and sustained the 30-year dividend growth track record, the integration has introduced significant balance sheet strain, evidenced by the loan-to-value ratio rising to 57% and a compression in debt maturity. This does not establish that the dividend is at immediate risk, as it remains fully covered by adjusted earnings. Investor Takeaway: The scale benefits of the merger are clear, but the resulting NAV dilution and elevated leverage neutralize the near-term equity appeal until management successfully executes its deleveraging targets.
Operational scale has improved but per-share metrics and leverage have deteriorated. Useful as thesis confirmation of merger execution, not as a fresh conviction trigger.
Decision framework
Current stance: Filing Neutral
Key drivers
- Net rental income surged by 49% to £230 million, reflecting the immediate scale benefits of the Assura merger.
- The company maintained its 30-year track record of consecutive dividend growth, with the 7.1p dividend fully covered by adjusted earnings.
- Post-merger integration is progressing ahead of schedule, with over 80% of targeted annualised transaction synergies already delivered.
Key risks
- Balance sheet leverage has deteriorated significantly, with the loan-to-value ratio rising to 57%, well above the target range of 40% to 50%.
- Per-share value has been diluted, evidenced by a 4.62% drop in HEPS and a 4.85% decline in IFRS net tangible assets per share.
- The debt profile has worsened, showing a compressed weighted average maturity of 4.1 years and an increased average cost of debt of 3.7%.
What would change the view
- Guidance and cash-flow quality both improve materially from current baseline.
- Subsequent filings remove current uncertainty and confirm durable execution.
- Market structure/positioning shifts enough to support a directional thesis.
Evidence from the filing
Net rental income grew by 49% to £230 million, reflecting the scale benefits of the recent transformational combination.
“Net rental income increased by 49% to £230 million (December 2024: £154 million)”
The company has achieved 30 consecutive years of dividend growth, with the current dividend remaining fully covered by adjusted earnings.
“We have now achieved PHP's 30-year anniversary of consecutive dividend growth and approach the future with a dedicated determination to continue growing our dividend on a fully covered basis.”
Integration of the Assura merger is progressing ahead of schedule, with over 80% of identified annualised transaction synergies already delivered.
“In a short space of time and ahead of schedule, we have delivered over 80% of the annualised transaction synergies”
Rental growth of 3.2% in 2025 exceeded previous guidance, with momentum continuing into 2026 at an annualised rate of 3.4% on settled rent reviews.
“Rental growth of 3.2% in 2025 was ahead of previous guidance and this trend has continued into 2026, with an annualised growth rate of 3.4% on rent reviews settled in the first two months.”
Strategic alignment with the NHS 10-year Health Plan and the Neighbourhood Rebuild programme provides a favorable long-term tailwind for the company's primary care asset portfolio.
“The NHS's 10-year Health Plan published in July 2025 is clearly positive for PHP. We welcome the Government's commitment to strengthening the NHS, particularly its emphasis on shifting more services to modern primary care facilities embedded in local communities, enhanced by the NHS Neighbourhood Rebuild programme announced in the Autumn Budget.”
The company's leverage has increased significantly, with the loan-to-value (LTV) ratio rising to 57% from 48% in the prior year, placing it well above the stated target range of 40% to 50%.
“Loan to value ratio of 57% (December 2024: 48%)”
The quality of the income stream has deteriorated, as the proportion of the rent-roll funded by government bodies dropped from 89% to 76%, increasing exposure to non-sovereign counterparty risk.
“Rent-roll funded by government bodies of 76% (December 2024: 89%)”
The debt maturity profile has compressed, with the weighted average debt maturity falling to 4.1 years from 5.7 years, while the average cost of debt has simultaneously risen to 3.7% from 3.4%.
“Average cost of debt of 3.7% (December 2024: 3.4%)”
Shareholders have experienced a dilution in net asset value, with IFRS net tangible assets per share declining by 4.85% to 98 pence.
“IFRS net tangible assets per share decreased by 4.85% to 98 pence (December 2024: 103 pence)”
More on Primary Health Prop PLC
Related filings
More from PHP
- PRIMARY HEALTH PROPERTIES PLC - Director/PDMR Shareholding
- PRIMARY HEALTH PROPERTIES PLC - Rule 19.6(c) confirmation with respect to post-offer intention statements regarding Assura plc
- PRIMARY HEALTH PROPERTIES PLC - Retail Investor Presentation via Investor Meet Company
- PRIMARY HEALTH PROPERTIES PLC - Unaudited interim results for the six months ended 30 June 2026
- PRIMARY HEALTH PROPERTIES PLC - CANCELLATION OF S524806 Unaudited interim results for the six months ended 30 June 2026
Other Results
- CCCCILO CYBIN HOLDINGS LIMITED - Audited Annual Consolidated Financial Statements for the Financial year ended 31 March 2026, Distribution of Integrated Annual Report and Notice of Annual General Meeting, and Availability of B-BBEE Annual Compliance Report
- SUISUN INTERNATIONAL LIMITED - Unaudited Interim Group Financial Results, Interim Ordinary Cash Dividend Declaration for the six months ended 30 June 2026 and Changes to Risk Committee Responsibilities
- AVIAVI LIMITED - RESULTS FOR THE YEAR ENDED 30 JUNE 2026, AND FINAL AND SPECIAL DIVIDEND
- BELBELL EQUIPMENT LIMITED - Unaudited Condensed Consolidated Interim Financial Statements for the six months ended 30 June 2026 and Dividend Declaration
- ARIAFRICAN RAINBOW MINERALS LIMITED - Condensed Reviewed Results for the financial year ended 30 June 2026 and Final Cash Dividend Declaration